Form 4: CEL SCI Corp Chief Scientific Officer Acquires Shares

Eyal Talor, Chief Scientific Officer of CEL SCI Corp, acquired 6,001 shares of common stock at a price of $0.40 per share on December 31, 2024.

Summary

• Eyal Talor, the Chief Scientific Officer of CEL SCI Corp, has reported a transaction involving the acquisition of company stock.
• On December 31, 2024, Mr. Talor acquired 6,001 shares of common stock.
• The purchase price for each share was $0.40.
• Following this transaction, Mr. Talor's total direct holdings in CEL SCI Corp amount to 124,597 shares.

Sentiment

Score: 6

Explanation: The document is neutral in sentiment, as it simply reports a stock transaction by an officer. It is neither particularly positive nor negative.

Positives

• The acquisition of shares by a key officer may indicate confidence in the company's future prospects.

Industry Context

This is a standard SEC Form 4 filing, which is common for company insiders who trade their company's stock. It provides transparency into the transactions of key personnel.

Comparison to Industry Standards

• SEC Form 4 filings are a standard practice for publicly traded companies in the United States.
• The reporting requirements are consistent across all companies and are designed to ensure transparency in insider trading activities.
• The transaction is typical for an officer of a company and does not indicate any unusual activity.

Stakeholder Impact

• The transaction may have a minor positive impact on shareholder sentiment, as it indicates confidence from a key officer.

Key Dates

Keywords

CEL SCI Corp, Eyal Talor, stock acquisition, insider trading, common stock, Chief Scientific Officer